Peters John Sheldon sold $169K of LMND

Peters John Sheldon (Chief Insurance Officer) sold 3,108 shares of Lemonade, Inc. (LMND) at an average of $54.50 ($54.45–$54.63, $0.17M total) across 2 trades over 2026-09-03 to 2026-09-04 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Peters John Sheldon
Published Sep 8, 2026, 9:33 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 8, 2026, 9:45 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$LMND
Neutral
medium confidence
Mentioned
$LMND
Relevance
3/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$LMNDNeutralLow
01

Why it matters

The disclosed sale is modest and likely already priced in; no immediate trading action recommended.

02

Market read

Minor insider sell with limited impact on Lemonade's stock price.

03

What to watch

The 10b5-1 plan pre-arranged nature reduces informational value of the sale.

Relevance 3/10Novelty 4/10Timing: filed today

Background

Form 4 filings disclose insider trades; investors monitor them for signals.

Company-level read

Ticker impact

$LMNDNeutralMedium confidence
Context

Chief Insurance Officer sold 3,108 shares for $169,385 via a 10b5-1 plan.

Expected impact

Potential short-term pressure of a few basis points, unlikely to move price materially.

Evidence & confidence

The sale is under $200k and represents a small fraction of holdings; typical for insiders with pre-arranged plans.

Market effects

No broader sector impact; isolated insider transaction.

Limited to U.S. equity market, no regional effect.

Minimal global relevance.

Counterpoint

Insider may be cashing out for personal reasons, not necessarily a lack of confidence in Lemonade.

Key entities

  • Peters John Sheldon

    Chief Insurance Officer of Lemonade, Inc.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$LMNDMed

Lemonade stock price target lowered to $45 by Keefe Bruyette

Keefe Bruyette & Woods lowered its price target on Lemonade Inc. (NYSE:LMND) to $45 from $48, citing higher growth spending and operating expenses. The firm noted Lemonade's premium growth exceeds 30% and revenue grew nearly 70% in the last twelve months. Lemonade reported Q3 2026 earnings, exceeding expectations with revenue of $336.1 million and adjusted loss of $0.56 per share.

$LMNDMed

Lemonade Q3 Earnings Call Highlights

Lemonade (LMND) reported Q3 operating expenses rose 36% YoY, driven by higher sales and marketing, and administrative costs. Adjusted free cash flow was $27M, with $1.2B in cash. Lemonade Car's premium grew 63% YoY, and the company expects slower growth spending. Loss ratios varied by product, with pet insurance under pressure. The company plans to discuss AI initiatives at its investor day.

$LMNDHighAI 8/10

Lemonade (LMND) Q3 2026 Earnings Call Transcript

Lemonade (LMND) reported Q3 2026 results: $1.55B in-force premium (+34%), $336.1M revenue (+73%), $118.1M gross profit (+48%), and $20.4M adjusted EBITDA loss (improved from prior year). Customer base grew 23% to 3.5M, with premium per customer up 9% to $440. Gross loss ratio increased to 65% due to inflation and weather events. Management expects Q4 adjusted EBITDA to be positive and full-year revenue between $1.23B and $1.235B.

$LMNDMed

Lemonade Inc (LMND) (Q3 2026) Earnings Call Highlights: Record Premium Growth and a Clear

Lemonade Inc (LMND) reported Q3 2026 earnings, highlighting record premium growth and strategic advantages from AI agents. CEO Daniel Schreiber noted AI's potential to favor Lemonade over incumbents. CFO Tim Bixby discussed car insurance loss ratios, G&A expenses, and pet insurance trends. The company expects accelerated state rollouts and cross-sales growth, with no significant incremental customer acquisition costs for cross-sold products.